# PAVBLU

NDC: 55513-065
Generic name: aflibercept-ayyh
Labeler / Manufacturer: Amgen, Inc
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION
Routes: INTRAVITREAL
Marketing started: 20241028

FDA application: BLA761298

## Active ingredients

- AFLIBERCEPT: 2 mg/.05mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"55513-065"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=55513-065
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c61062f3-80ec-4a20-8c28-46e468592a06